|
|
|
|
| LEADER |
04147nma a2201081 u 4500 |
| 001 |
EB002158217 |
| 003 |
EBX01000000000000001296332 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230515 ||| eng |
| 020 |
|
|
|a 9783036569895
|
| 020 |
|
|
|a 9783036569888
|
| 020 |
|
|
|a books978-3-0365-6988-8
|
| 100 |
1 |
|
|a Boschi, Alessandra
|
| 245 |
0 |
0 |
|a Metal-Based Radiopharmaceuticals in Inorganic Chemistry
|h Elektronische Ressource
|
| 260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2023
|
| 300 |
|
|
|a 1 electronic resource (192 p.)
|
| 653 |
|
|
|a cobalt-55
|
| 653 |
|
|
|a auger emission
|
| 653 |
|
|
|a calixarenes
|
| 653 |
|
|
|a technetium-99m
|
| 653 |
|
|
|a reconstituted high-density lipoproteins
|
| 653 |
|
|
|a in-flow chemistry
|
| 653 |
|
|
|a PET
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a liquid-liquid extraction
|
| 653 |
|
|
|a DFT
|
| 653 |
|
|
|a Inorganic chemistry / bicssc
|
| 653 |
|
|
|a indium-111 labelling
|
| 653 |
|
|
|a radiopharmaceuticals
|
| 653 |
|
|
|a manganese-52
|
| 653 |
|
|
|a microfluidics
|
| 653 |
|
|
|a gallium-68
|
| 653 |
|
|
|a rhenium complexes
|
| 653 |
|
|
|a automation
|
| 653 |
|
|
|a optical imaging
|
| 653 |
|
|
|a copper radionuclides production
|
| 653 |
|
|
|a barium
|
| 653 |
|
|
|a cholecystokinin-2 receptor
|
| 653 |
|
|
|a radiopharmaceutical
|
| 653 |
|
|
|a radionuclide production
|
| 653 |
|
|
|a cobalt isotopes
|
| 653 |
|
|
|a scavenger receptor B type I
|
| 653 |
|
|
|a radiometals production
|
| 653 |
|
|
|a click chemistry
|
| 653 |
|
|
|a cyclotron production
|
| 653 |
|
|
|a 165Er
|
| 653 |
|
|
|a nastorazepide
|
| 653 |
|
|
|a theranostics
|
| 653 |
|
|
|a Research & information: general / bicssc
|
| 653 |
|
|
|a chelation
|
| 653 |
|
|
|a extraction chromatography
|
| 653 |
|
|
|a chemical derivatization
|
| 653 |
|
|
|a radiochemistry
|
| 653 |
|
|
|a lanthanide separation
|
| 653 |
|
|
|a Cu-67
|
| 653 |
|
|
|a erbium-165
|
| 653 |
|
|
|a photonuclear method
|
| 653 |
|
|
|a fluorescence
|
| 653 |
|
|
|a fusarinine C
|
| 653 |
|
|
|a nuclear medicine
|
| 653 |
|
|
|a invasive fungal infections
|
| 653 |
|
|
|a coordination chemistry
|
| 653 |
|
|
|a zirconium-89
|
| 653 |
|
|
|a 225Ac-rHDL
|
| 653 |
|
|
|a targeted alpha-particle therapy
|
| 653 |
|
|
|a radioimmunotherapy
|
| 653 |
|
|
|a radiolabelling
|
| 653 |
|
|
|a Zirconium-89
|
| 653 |
|
|
|a dogs
|
| 653 |
|
|
|a 1-3-beta-glucan
|
| 653 |
|
|
|a Chemistry / bicssc
|
| 653 |
|
|
|a actinium-225
|
| 653 |
|
|
|a targeted radionuclide therapy
|
| 653 |
|
|
|a solid targets
|
| 653 |
|
|
|a dissolution system
|
| 653 |
|
|
|a bismuth-213
|
| 653 |
|
|
|a high-resolution mass spectrometry
|
| 700 |
1 |
|
|a Martini, Petra
|
| 700 |
1 |
|
|a Boschi, Alessandra
|
| 700 |
1 |
|
|a Martini, Petra
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 028 |
5 |
0 |
|a 10.3390/books978-3-0365-6988-8
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/6962
|7 0
|x Verlag
|3 Volltext
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/98909
|z DOAB: description of the publication
|
| 082 |
0 |
|
|a 000
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 333
|
| 082 |
0 |
|
|a 540
|
| 082 |
0 |
|
|a 700
|
| 520 |
|
|
|a The field of radiopharmaceuticals is constantly evolving thanks to the great contributions of specialists coming from different disciplines such as inorganic chemistry, radiochemistry, organic and biochemistry, pharmacology, nuclear medicine, physics, etc. In particular, the use of radiometals has experienced a great increase as a result of the development of radionuclides production technologies. In this particular area, inorganic chemistry skills are mainly involved in developing target-specific radiopharmaceuticals based on radiometals for non-invasive disease detection and cancer radiotherapy.The Special Issue "Metal-Based Radiopharmaceuticals in Inorganic Chemistry" includes eleven research articles and one review. The production and applications of conventional and newly emerging research radiometals for diagnosis, therapy, and theranostics are the main focus of this Special Issue.
|